A clinical investigation on tong xin luo capsule in treatment of coronary heart disease with silent myocardial ischemia.

Journal Article (Clinical Trial;Journal Article)

36 cases of coronary heart disease with silent myocardial ischemia (SMI) were treated sequentially with Tong Xin Luo (TXL) capsule and isosorbide dinitrate in random order. The results showed that both drugs were effective in decreasing episodes of SMI and shortening the duration of asymptomatic myocardial ischemia. TXL, however, was found with a better action and was superior to isosorbide dinitrate. It was also found that TXL could improve diastolic function of the left ventricle as well.

Full Text

Duke Authors

Cited Authors

  • Zhang, Y; Zhou, H; Wang, E

Published Date

  • June 2000

Published In

Volume / Issue

  • 20 / 2

Start / End Page

  • 93 - 95

PubMed ID

  • 11038993

International Standard Serial Number (ISSN)

  • 0255-2922


  • eng

Conference Location

  • China